Thitame and colleagues reviewed the published literature on spirulina’s capacity to bind and excrete heavy metals from the body and to protect liver function. The review describes phycocyanin, polysaccharides, and amino acids including cysteine and glutamate as the principal chelating agents in spirulina biomass. No original food or supplement concentration measurements were generated; all numerical findings cited in this source page are from studies referenced by the review authors.
Key numbers
This is a narrative review. No original measurements are reported. The following values come from secondary sources cited by the review and are not independently verified in this paper.
Animal model findings cited by the review:
- Gholamian et al. (cited as Reference 7): rat supplementation with spirulina produced “considerable reductions” of cadmium buildup in liver and kidney tissue; exact concentrations not reprinted in the review
- Choi et al. (cited as Reference 12): clinical trial in patients with non-alcoholic fatty liver disease showed noteworthy decreases in AST and ALT liver enzyme levels following spirulina supplementation; heavy metal concentrations not measured
Chelation mechanism described:
- Phycocyanin: antioxidant pigment-protein complex that acts as a free radical scavenger; described as capable of binding mercury and lead in the algal biomass
- Polysaccharides: described as able to extract heavy metals from bloodstreams and tissues
- Cysteine: amino acid in spirulina protein contributing to glutathione production, the body’s primary antioxidant involved in liver detoxification
- Vitamins B-complex, C, E, A and minerals iron, magnesium, calcium: described as supporting liver enzyme function and anti-inflammatory response
No supplement arsenic or lead concentration data are reported in this review.
Methods (brief)
Narrative review; no systematic search protocol, inclusion/exclusion criteria, or risk-of-bias assessment is described. No LOD/LOQ, CRM, or recovery data are applicable. The review synthesizes primarily animal studies and limited human clinical data on spirulina’s liver and detoxification effects.
Evidence fitness
Supports:
- Mechanistic explanation for why spirulina accumulates heavy metals from its cultivation environment: the same phycocyanin and polysaccharide binding capacity used for proposed chelation applications means spirulina will sequester metals present in contaminated growth water or substrate
- Background context for why spirulina and chlorella marketed as greens/superfood supplements carry elevated lead, cadmium, and other metals relative to terrestrial plant supplements: biosorption is a defining property of these organisms
Does not support:
- Heavy metal concentrations in finished spirulina or chlorella supplements
- Population-level exposure estimates from supplement use
- Arsenic or mercury measurements in spirulina products (not addressed)
- Clinical efficacy of spirulina as a detoxification treatment (review is exploratory; authors call for further human trials)
Limitations
The review is a narrative synthesis with no documented systematic search strategy. Cited primary studies are largely animal models (rat), with limited human clinical trial data. The review does not report finished-product concentration measurements and cannot serve as a source of food or supplement occurrence data for this wiki row. The connection between spirulina’s in vivo chelation capacity and its environmental bioaccumulation of contaminants is stated mechanistically but not quantified for the finished-product form.
Related evidence
- Ingredient class — greens/superfood blends (Pb/cadmium (Cd)/inorganic arsenic (iAs) hyperaccumulator)
- Ingredient class — algae/seaweed-based
- Lead
- Cadmium
- Mercury
- Spirulina and Chlorella Dietary Supplements—Are They a Source Solely of Valuable Nutrients?
Update history
No substantive edit history is available in this build. The full commit record is available in git.